Original Research
Accepted on 12 Feb 2026
The CNS compartmentalized IgG aggregates and glycosylation in multiple sclerosis contribute to oligoclonal bands and neuronal cytotoxicity
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Type at least 3 characters
1,513 articles
articles
Retraction
Accepted on 12 Feb 2026
Retraction: The intra-nuclear SphK2-S1P axis facilitates M1-to-M2 shift of microglia via suppressing HDAC1-mediated KLF4 deacetylation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 11 Feb 2026
Phosphoproteomics Uncovers a Neuroimmune Perspective on Trigeminal Neuralgia: Sexually Dimorphic Regulatory Networks Linking Calcium Channels to the Complement Cascade
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 10 Feb 2026
EEG biomarkers of microstructural damage in normal-appearing white matter among patients with neuromyelitis optica spectrum disorder: A DTI-EEG combined study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 09 Feb 2026
An integrated analysis of spinal cord transcriptome and gut microbiome unravel age-associated host-microbiome interactions following spinal cord injury
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Accepted on 09 Feb 2026
Insights into the Potential Pathogenesis and Therapeutic Implications of Ferroptosis in Brain Microvascular Endothelial Cells During Stroke
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 240 views
Mini Review
Accepted on 09 Feb 2026
An updated review of the economic burden of Multiple Sclerosis: Direct and indirect costs
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 09 Feb 2026
Putative α7-selective ligands interact with α9-containing nicotinic acetylcholine receptors and modulate immune functions of human mononuclear phagocytes
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Hypothesis and Theory
Accepted on 09 Feb 2026
Infection, vaccination and risk of dementia: a proposed immunological model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Published on 09 Feb 2026
Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1752245
- 455 views
Original Research
Accepted on 06 Feb 2026
MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer's disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 06 Feb 2026
Deep Gray Matter Atrophy Mediates the Associations Between Glymphatic Dysfunction and Clinical Disability in Relapsing-Remitting Multiple Sclerosis: A Neuroimaging Subgroup Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 04 Feb 2026
Mitochondrial Transplantation Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Th17/Treg Balance and Restoring Metabolic Homeostasis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 269 views
Original Research
Accepted on 04 Feb 2026
Dysbiosis of intestinal microbiota in patients with neuromyelitis optica spectrum disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Accepted on 04 Feb 2026
TREM2 and Microglial Immunity in Alzheimer's Disease: Mechanisms, Genetics, and Therapeutic Opportunities
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 112 views
Original Research
Accepted on 04 Feb 2026
Dysregulated NK cell gene expression defines the enduring symptoms of long COVID-19
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 160 views
Original Research
Published on 04 Feb 2026
Prognostic factors and a preliminary prognostic model in anti-GAD antibody-associated epilepsy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1738062
- 593 views
Original Research
Accepted on 03 Feb 2026
Immune correlates underlying Small Fiber Neuropathy presenting as Vaccine-associated Post-Acute SARS-Coronavirus Syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 402 views
Original Research
Accepted on 02 Feb 2026
Targeting the Oxidative Stress-Neuroinflammation Axis: The Mechanism of Arctigenin's Broad-Spectrum Analgesia with Limited Side Effects
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 119 views
Original Research
Published on 02 Feb 2026
Lupeol restores dopaminergic function by suppressing glial activation in a Parkinson’s disease mouse model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1708581
- 737 views
Original Research
Published on 02 Feb 2026
Impact of preanalytical factors on blood CHI3L1 levels
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1720914
- 579 views
Original Research
Accepted on 31 Jan 2026
Kappa Free Light Chain index in CSF diagnostics: The impact of different Immunoglobulin Isotypes
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 200 views
Original Research
Accepted on 28 Jan 2026
A real-world study of ublituximab based on the WHO-VigiAccess and U.S. Food and Drug Administration's adverse event reporting system databases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 242 views
Original Research
Published on 28 Jan 2026
Safety and efficacy of B-cell therapy in older people with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1699550
- 895 views